InvestorLens

ASND — ASCENDIS PHARMA A/S

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ASCENDIS PHARMA A/S (ASND)

ASCENDIS PHARMA A/S (ASND) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $70M. Across recent filings, tracked investors recorded 6 new positions, 1 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ASND

100
/100
Strong Institutional Accumulation
Added / Increased7
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track ASND

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

ASND Ownership Composition

How ASCENDIS PHARMA A/S is held across tracked investor types, based on reported 13F positions.

Dominant Type
Hedge Funds
51% of tracked value
Institutions
4
tracked investors
Total Reported
$138M
combined 13F value
Sectors2
  • Hedge Funds51.1%
  • Other48.9%
Hedge Funds(1)
51.1%
Other(3)
48.9%

Tracked investors reporting ASND

  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    47.8M
    Value
    $70.5M
    % Portfolio
    0.09%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    189K
    Value
    $43.2M
    % Portfolio
    0.02%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    67.6K
    Value
    $15.5M
    % Portfolio
    0.00%
  • Paul Tudor JonesMar 31, 2026
    Tudor Investment Corp
    Shares
    38.6K
    Value
    $8.8M
    % Portfolio
    0.02%

Recent activity

Frequently asked questions

How many institutional investors hold ASND?
4 tracked institutional investors disclosed a position in ASND (ASCENDIS PHARMA A/S) in their most recent 13F filing.
Who is the largest institutional holder of ASND?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ASND, valued at $70M.
Did institutional ownership of ASND increase or decrease?
Across recent 13F filings, tracked investors recorded 6 new positions, 1 increased, 0 reduced, and 0 fully exited ASND.
Where does this ASND ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
ASND (ASCENDIS PHARMA A/S) — Institutional Holders & 13F — InvestorLens